ZSCAN22 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.462800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.568400E-01
Normal-vs-Stage2
8.950400E-01
Normal-vs-Stage3
1.685150E-01
Normal-vs-Stage4
5.043600E-02
Stage1-vs-Stage2
3.169200E-01
Stage1-vs-Stage3
1.740390E-01
Stage1-vs-Stage4
8.137600E-01
Stage2-vs-Stage3
1.031790E-01
Stage2-vs-Stage4
4.922900E-03
Stage3-vs-Stage4
1.021880E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.297800E-01
Normal-vs-AfricanAmerican
9.309600E-01
Normal-vs-Asian
5.085200E-01
Caucasian-vs-AfricanAmerican
8.198200E-01
Caucasian-vs-Asian
2.214800E-01
AfricanAmerican-vs-Asian
4.889800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.875800E-01
Normal-vs-Female
8.998800E-01
Male-vs-Female
5.611400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.926800E-01
Normal-vs-Age(41-60Yrs)
5.316000E-01
Normal-vs-Age(61-80Yrs)
8.687200E-01
Normal-vs-Age(81-100Yrs)
1.269380E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.736400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.686000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.805600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.602600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.777020E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.569900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.500400E-01
Normal-vs-Daily Drinker
8.251000E-01
Normal-vs-Weekly Drinker
8.260000E-01
Normal-vs-Occasional Drinker
5.284800E-01
Normal-vs-Social Drinker
6.692600E-01
Non Drinker-vs-Daily Drinker
2.324800E-01
Non Drinker-vs-Weekly Drinker
5.141700E-02
Non Drinker-vs-Occasional Drinker
3.079900E-03
Non Drinker-vs-Social Drinker
1.445620E-02
Daily Drinker-vs-Weekly Drinker
4.386400E-01
Daily Drinker-vs-Occasional Drinker
1.118830E-01
Daily Drinker-vs-Social Drinker
2.548000E-01
Weekly Drinker-vs-Occasional Drinker
5.153200E-01
Weekly Drinker-vs-Social Drinker
7.842800E-01
Occasional Drinker-vs-Social Drinker
6.872800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.461600E-01
Normal-vs-Grade 2
9.164800E-01
Normal-vs-Grade 3
9.465600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.407000E-01
Grade 1-vs-Grade 3
2.100000E-01
Grade 1-vs-Grade 4
6.461600E-01
Grade 2-vs-Grade 3
4.540200E-01
Grade 2-vs-Grade 4
9.164800E-01
Grade 3-vs-Grade 4
9.465600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.889200E-01
Normal-vs-NonDiabetic
9.181800E-01
Diabetic-vs-NonDiabetic
2.843600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.377000E-01
Normal-vs-NoPancreatitis
9.829400E-01
Pancreatitis-vs-NoPancreatitis
7.071400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.452200E-01
Normal-vs-N1
9.813800E-01
N0-vs-N1
7.411400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.825200E-01
Normal-vs-TP53-NonMutant
6.657200E-01
TP53-Mutant-vs-TP53-NonMutant
1.712750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
